April 30, 2018

ATTENTION: Beginning May 7th, our Weekly Broadcast will have a NEW and INTERACTIVE look to provide easier navigation!

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link for your convenience.

ACTIVATIONS
GENITOURINARY
NRG-GU006: A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy with or without Enhanced Anti-androgen Therapy with Apalutamide in Recurrent Prostate Cancer, NCT # 03371719.  Activation Date: April 27, 2018. Documents are posted on CTSU.

FORM UPDATES
CANCER PREVENTION & CONTROL
NRG-CC004: The PHQ4 form has been revised and is available on the CIRB tab on CTSU.  Use the revised version date of April 4, 2018 immediately.

OTHER PROTOCOL NOTICES
CANCER PREVENTION & CONTROL
NRG-CC004: A patient flyer has been reviewed and approved by CIRB for this study. The flyer is available on the CIRB tab on CTSU. Sites using their local IRB must obtain approval prior to use.

VTOC Training
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for May 9, 2018.

DRUG SAFETY UPDATES AND INVESTIGATOR BROCHURE NOTICES
Safety updates have been issued for the following NRG Oncology studies:
- Cabozantinib: NRG-GY001
- Ipilimumab: NRG-BN002 and NRG-GY003
- Nivolumab: NRG-BN002, NRG-GY002, NRG-GY003
  • For NRG-GY001 safety reports, please see CTSU.
  • For NRG-BN002, NRG-GY002, and NRG-GY003 safety reports, please see the protocol page on NRG Oncology.

An Investigator’s Brochure notice has been issued for the following studies:
Atezolimumab: NRG-GI004, NRG-GY0009

The current version of the Investigator Brochure Documents (IB-Summary of Changes) for Atezolizumab (MPDL3280A) NSC 783608 for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials are available for access via the Cancer Therapy Evaluation Program (CTEP) Online Agent Order Processing (OAOP) website ( https://ctepcore.nci.nih.gov/OAOP/).  Log-in using your Identity and Access Management (IAM) username and password credentials and provide the requested information to access the document.

Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).

APPLICATIONS FOR NRG ONCOLOGY BREAST COMMITTEE NOW OPEN
The NRG Oncology Breast Committee is accepting applications for membership. If you or someone at your site is interested in becoming a member of the Breast Committee, please complete  the application (available on the NRG Oncology website: go to the Scientific Program tab, click on Disease Site Committees, then click Breast Cancer) and  submit it on or before the deadline, May 31, 2018.  If you have any questions, please contact Toni Arthurs at ArthursT@NRGOncology.org.

NRG Oncology’s Publications Policy & Guidelines have recently been updated. The new policy and guidelines document can be found on the NRG Oncology website . Please pay close attention to the changes made regarding manuscripts and abstracts.

PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings
American College of Radiology (ACR) ; May 19-23, 2018; Washington DC
American Radium Society (ARS); May 5-8, 2018; Orlando, FL
American Society of Breast Surgeons (ASBS); May 2-6, 2018; Orlando, FL
American Society of Clinical Oncology (ASCO); Jun 1-5, 2018; Chicago, IL
American Society of Colon and Rectal Surgeons (ASCRS); May 19-23, 2018; Nashville, TN
American Urology Association (AUA); May 18-21, 2018; San Francisco, CA
Digestive Disease Week (DDW); May 21-24, 2018; San Diego, CA
Society for Clinical Trials (SCT); May 20-23, 2018; Portland, OR

Upcoming Abstract Submission Deadlines
American Society for Radiation Oncology (ASTRO); Oct 21-24, 2018; San Antonio, TX; Late-breaking Aug 1, 2018
European Society for Medical Oncology (ESMO); Oct 19-23, 2018;Munich, Germany; due to publications committee Apr 25, 2018; meeting abstracts submission deadline May 9, 2018; Late-breaking Sep 17, 2018
International Gynecologic Cancer Society (IGCS); Sep 14-16, 2018; Kyoto, Japan; due to publications committee Apr 27, 2018; meeting abstracts submission deadline May 9, 2018
Society for Neuro-Oncology (SNO); Nov 15-18, 2018; New Orleans, LA; due to publications committee May 21, 2018; meeting abstracts submission deadline June 4, 2018

Please  click here to participate in a brief survey regarding our NRG Oncology website protocol table. We would love to hear your opinions and any suggestions you may have to improve your experience.


NRG Oncology is proud to be an active participant of #CancerMoonShot.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse